Biogen Inc.
BIIB
$186.26
$2.241.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -110.48% | -26.51% | 163.95% | -9.82% | -31.35% |
| Total Depreciation and Amortization | -0.99% | 4.07% | 6.06% | -0.43% | 0.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.24% | 253.87% | -28.21% | -40.01% | 116.02% |
| Change in Net Operating Assets | -162.40% | 122.06% | -136.76% | -1,278.45% | -87.90% |
| Cash from Operations | -59.77% | 690.86% | -37.95% | -65.92% | -18.67% |
| Capital Expenditure | 4.98% | -73.68% | 28.30% | 5.60% | -12.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10,800.90% | 136.51% | -198.04% | -149.28% | 129.03% |
| Cash from Investing | -3,409.12% | 38.42% | -20.51% | -154.30% | 98.43% |
| Total Debt Issued | 100.00% | -100.02% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 210.08% | -2,751.02% | 121.30% | -391.14% | 219.70% |
| Cash from Financing | -5.22% | -1,012.82% | 49.13% | -391.14% | 219.70% |
| Foreign Exchange rate Adjustments | 178.13% | -104.69% | 99.13% | 146.10% | -275.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.38% | 587.85% | -28.12% | -66.96% | 422.27% |